Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,832 | 64,441 | 69,227 | 123,652 | 82,537 |
| Marketable Securities | 169,256 | 214,671 | 226,944 | 199,459 | 267,080 |
| Receivables | 126 | 244 | 245 | 10,187 | 2,422 |
| TOTAL | $271,139 | $286,354 | $305,555 | $340,829 | $358,603 |
| Non-Current Assets | |||||
| PPE Net | 15,419 | 14,156 | 13,257 | 12,032 | 11,559 |
| Investments And Advances | 0 | 39,195 | 80,605 | 104,024 | 96,797 |
| Other Non-Current Assets | 41,009 | 45,096 | 40,930 | 42,268 | 37,691 |
| TOTAL | $56,428 | $98,447 | $134,792 | $158,324 | $146,047 |
| Total Assets | $327,567 | $384,801 | $440,347 | $499,153 | $504,650 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,491 | 13,769 | 7,966 | 8,269 | 10,411 |
| Accrued Expenses | 28,785 | 27,669 | 31,481 | 34,563 | 30,278 |
| TOTAL | $72,353 | $74,306 | $66,487 | $63,217 | $58,603 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 14,684 | 14,684 | 14,684 | 8,221 | 8,221 |
| Other Non-Current Liabilities | 25,376 | 24,282 | 25,256 | 26,172 | 24,918 |
| TOTAL | $79,580 | $78,486 | $79,460 | $86,839 | $85,585 |
| Total Liabilities | $151,933 | $152,792 | $145,947 | $150,056 | $144,188 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,548 | 82,476 | 82,238 | 81,814 | 81,674 |
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -1,423,048 | -1,360,907 | -1,293,300 | -1,231,350 | -1,212,476 |
| Other shareholders' equity | 522 | -442 | -326 | 198 | -1,452 |
| TOTAL | $175,634 | $232,009 | $294,400 | $349,097 | $360,462 |
| Total Liabilities And Equity | $327,567 | $384,801 | $440,347 | $499,153 | $504,650 |